KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Accumulated Expenses (2016 - 2025)

Charles River Laboratories International has reported Accumulated Expenses over the past 17 years, most recently at $270.1 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $270.1 million for Q4 2025, up 50.53% from a year ago — trailing twelve months through Dec 2025 was $270.1 million (up 50.53% YoY), and the annual figure for FY2025 was $270.1 million, up 50.53%.
  • Accumulated Expenses for Q4 2025 was $270.1 million at Charles River Laboratories International, roughly flat from $269.7 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for CRL hit a ceiling of $270.1 million in Q4 2025 and a floor of $176.1 million in Q2 2023.
  • Median Accumulated Expenses over the past 5 years was $210.7 million (2023), compared with a mean of $214.8 million.
  • Biggest five-year swings in Accumulated Expenses: surged 58.74% in 2021 and later dropped 22.51% in 2023.
  • Charles River Laboratories International's Accumulated Expenses stood at $228.8 million in 2021, then decreased by 13.86% to $197.1 million in 2022, then rose by 8.23% to $213.3 million in 2023, then decreased by 15.88% to $179.4 million in 2024, then soared by 50.53% to $270.1 million in 2025.
  • The last three reported values for Accumulated Expenses were $270.1 million (Q4 2025), $269.7 million (Q3 2025), and $227.5 million (Q2 2025) per Business Quant data.